Interleukin-1 expression in inflammatory myopathies: Evidence of marked immunoreactivity in sarcoid granulomas and muscle fibres showing ischaemic and regenerative changes

Neuropathology and Applied Neurobiology

Volumn 23, Issue 2, 1997, Pages 132-140

  Authier, F J ^a,b   Mhiri, C ^c   Chazaud, B ^a   Christov, C ^a,d   Cherin, P ^e   Barlovatz Meimon, G ^a   Gherardi, R K ^a,b  

^a UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^b HENRI MONDOR HOSPITAL   (France)

^c HABIB BOURGUIBA HOSPITAL   (Tunisia)

^d UNIVERSITY HOSPITAL ALEXANDROVSKA   (Bulgaria)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Dermatomyositis; Inflammatory myopathies; Interleukin 1; Saroidosis; Skeletal muscles

Indexed keywords

INTERLEUKIN 1; NERVE CELL ADHESION MOLECULE;

ARTICLE; AUTOIMMUNITY; CLINICAL ARTICLE; DERMATOMYOSITIS; GRANULOMA; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; INCLUSION BODY MYOSITIS; INFLAMMATORY CELL; MUSCLE BIOPSY; MUSCLE ISCHEMIA; MUSCLE REGENERATION; MYOPATHY; NERVOUS SYSTEM INFLAMMATION; POLYMYOSITIS; PRIORITY JOURNAL; SARCOIDOSIS;

EID: 0030977173     PISSN: 03051846     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2990.1997.tb01195.x     Document Type: Article

References (38)

1. Ascer E, Mohan C, Gennaro M, Cupo S. Interleukin-1β and thromboxane release after skeletal muscle ischaemia and reperfusion. Ann Vasc Surg 1992; 6: 69-73
2. Auron PE, Webb AC, Rosenwasser LJ et al. Nucleotide sequence of human monocyte IL-1 precursor cDNA. Proc Natl Acad Sci USA 1984; 81: 7907-11
3. Authier FJ, Belec L, Barlovatz-Meimon G, Gherardi RK. Interleukin-1 and skeletal muscle. Neuropathol Appl Neurobiol 1996 22 suppl; 1: 37-8
4. Ballmer PE, McNurlan MA, Southorn BG, Grant I, Garlick PJ. Effects of human recombinant interleukin-1 beta on protein synthesis in rat tissues compared with a classical acute-phase reaction induced by turpentine. Rapid response of muscle to interleukin-1 beta. Biochem J 1991; 279: 685-8
5. Banker BQ. Other inflammatory myopathies. In: Myology, Eds Engel AE, Franzini-Armstrong C. New York: McGraw-Hill, 1994: 1461-86
6. Baracos V, Rodeman HP, Dinarello CA, Goldberg AL. Stimulation of muscle protein degradation and prostaglandin E2 release by leucocyte pyrogen (interleukin-1). N Engl J Med 1983; 308: 553-58
7. Beesley JE, Bomford R, Schmidt JA. Ulstrastructural localization of Interleukin 1 in human peripheral blood monocytes: evidence for IL-1β in mitochondria. Histochem J 1989; 22: 234-44
8. Cannon JG, Fielding RA, Fiatarone MA, Orencole SF, Dinarello CA, Evans WJ. Increased interleukin-1β in human skeletal muscle after exercise. Am J Physiol 1989; 257: R451-5
9. Carpenter S, Karpati G. The pathological diagnosis of specific inflammatory myopathies. Brain Pathol 1992; 2: 13-9
10. Chensue SW, Otterness IG, Higashi GI, Forsh CS, Kunkel SL. Monokine production by hypersensitivity (Shistosoma mansoni egg) and foreign body (Sephadex bead)-type granuloma macrophages. Evidence for sequential production of IL-1 and tumor necrosis factor. J Immunol 1989; 142: 1281-6
11. Chilosi M, Menestrina F, Capelli et al. Immunohistochemical analysis of sarcoid granulomas. Evaluation of Ki 67+ and interleukin-1+ cells. Am J Pathol 1988; 131: 191-8
12. Clowes GHA, George BC, Villee CA, Saravis CA. Muscle proteolysis induced by a circulating peptid in patients with sepsis or trauma. N Engl J Med 1983; 308: 545-52
13. Corradi A, Franzi AT, Rubartelli A. Synthesis and secretion of interleukin-1α and interleukin-1 receptor antagonist during differenciation of cultured keratinocytes. Exp Cell Res 1995; 217: 355-62
14. Denis M. Interleukin-1 (IL-1) is an important cytokine in granulomatous ulveolitis. Cell Immunol 1994; 157: 70-80
15. Devergne O, Emilie D, Peuchmaur M, Crevon MC, D'Agay MF, Galanaud P. Production of cytokines in sarcoid lymph nodes: preferential expression of interleukin-1β and interferon-γ genes. Hum Pathol 1992; 23: 317-23
16. Dinarello CA. Interleukin-1 and interleukin-1 antagonism. Blood 1991; 77: 1627-52
17. Dinarello CA. The biological properties of interleukin-1. Eur Cytokine Netw 1994; 5: 517-31
18. Engel AG, Arahata K. Mononuclear cells in myopathies. Hum Pathol 1986; 17: 704-21
19. Flores EA, Bistrian BR, Pomposelli JJ, Dinarello CA, Blackburn GL, Istfan NW. Infusion of tumor necrosis factor/ cachectin promotes muscle catabolism in the rat. A synergistic effect with inteleukin 1. J Clin Invest 1989; 83: 1614-622
20. Gabay C, Gray-Croisier F, Roux-Lombard P et al. Elevated serum levels of interleukin-1 receptor antagonist in polymyositis/dermatomyositis. A biologic marker of disease activity with a possible role in the lack of acute phase protein response. Arthritis Rheum 1994; 37: 1744-55
21. Gherardi R, Florea-Strat A, Fromont G, Poron F, Sabourin JC, Authier FJ. Cytokine expression in the muscle of HIV-infected patients: evidence for IL-1α accumulation in mitochondria of AZT fibers. Ann Neurol 1994; 36: 752-8
22. Griffin WST, Sheng JG, Roberts GW, Mrak RE. Interleukin-1 expression in different plaque types in Alzheimer's disease: significance in plaque evolution. J Neuropathol Exp Neurol 1995; 54: 276-81
23. Illa I, Leon-Monzon M, Dalakas M. Regenerating and denervated human muscle fibers and satellite cells express neural cell adhesion molecules recognized by monoclonal atibodies to natural killer cells. Ann Neurol 1992; 31: 46-52
24. Karpati G, Carpenter S. Pathology of the inflammatory myopathies. In: Inflammatory myopathies, Ed Mastaglia FL. London: Baillière Tindall. 1993: 527-56
25. Leon-Monzon M, Dalakas MC. Interleukin-1 (IL-1) is toxic to human muscle. Neurology 1994; 44 (suppl 2): A132
26. Lundberg I, Engel AG. Restricted cytokine expression in muscles in inflammatory myopathies. Neurology 1994; 44 (Suppl 2): A346
27. Mendell JR, Sahenk Z, Gales T, Paul L. Amyloid filaments in inclusion body myositis. Arch Neurol 1991; 48: 1229-34
28. O'Brien JM, Wewers MD, Moore SA, Allen JN. Taxol and colchicine increase LPS-induced pro-IL-1β production but do not increase IL-1β secretion. J Immunol 1995; 154: 4113-22
29. Porreca E, Feliciani C, Di Febbo C et al. Modulation of rat vascular smooth muscle cell (VSMC) proliferation by cysteinyl-leukotriene D4: a role for mediation of IL-1. Atherosclerosis 1995; 113: 11-8
30. Schubert W, Kontozis L, Sticker G, Schwan H, Haraldsen G, Jerusalem F. Immunofluorescent evidence for presence of interleukin-1 in normal and diseased human skeletal muscle. Muscle Nerve 1988; 11: 890-2
31. Tews DS, Goebel HH. Cytokine expression profile in idiopathic inflammatory myopathy. J Neuropathol Exp Neurol 1996; 55: 342-7
32. Vaux DL, Haecker G, Strasser A. An evolutionary perspective on apoptosis. Cell 1994; 76: 777-79
33. Wolf RE, Baethge BA. Interleukin-1α, interleukin-2, and soluble interleukin-2 receptors in polymyositis. Arthritis Rheum 1990; 33: 1007-14
34. Whitman ED, Doherty GM, Peplinski GR, Norton JA. Role of cytokines in oxidative damage. In: Human Cytokines: Their Role in Disease and Therapy, Eds Aggarwal BB, Puri RK. Oxford: Blackwell Science, 1995: 333-51
35. Wiessner C, Ghermann J, Lindholm D, Topper R, Kreutzberg GW, Hossman KA. Expression of transforming growth factor-beta 1 and interleukin-1 beta mRMA in rat brain following transient forebrain ischaemia. Acta Neuropathol 1993; 86: 439-46
36. Wynn TA, Eltoum I, Cheever AW, Lewis FA, Gause WC, Sher A. Analysis of cytokine mRNA expression during primary granuloma formation induced by eggs of Schistosoma mansoni. J Immunol 1993; 151: 1430-40
37. Zamir O, Hasselgren PO, James H, Higashiguchi T, Fischer JE. Effect of tumor necrosis factor or interleukin-1 on muscle aminoacid uptake and the role of glucocorticoids. Surg Gynecol Obst 1993; 177: 27-32
38. Zamir O, Hasselgren PO, von Allmen D, Fischer JE. The filed of interleukin-1 alpha and the glucocorticoid receptor blocker RU 38486 on total and myofibrillar protein breakdown in skeletal muscle. J Surg Res 1991; 50: 579-83